Tilray Brands (TLRY) Stock Price, Quote, News & History

Tilray Brands Inc (TLRY) Stock Price, Quote, News & History

TLRYNASDAQ

Trade with Public

$6.44

-0.13-1.98%

Last update: Apr 13, 9:30 AM

Key Statistics

Open

$6.48

Volume / Avg.

1.68M / 3.38M

Day Range

$6.36 - $6.75

52 Wk Range

3.51 - 23.20

Market Cap

$748.49M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

12.36%

Days to Cover

5.95

Recent Tilray Brands Inc News

What's Going On With Tilray Brands Stock On Wednesday?

Tilray shares gained after launching a high-potency cannabis brand, with innovation and strong momentum outweighing mixed technical signals.

Nabaparna Bhattacharya

Tilray Stock Continues To Climb After Earnings Beat, Record Revenue

Tilray Brands shares are trading higher Thursday afternoon after the company's fiscal Q3 results topped Wall Street expectations.

Henry Khederian

Tilray Brands Reaffirms Outlook After Record Quarter

Tilray (TLRY) shares jump in premarket after record Q3 results. Adjusted EPS of $0.02 beats estimates as revenue hits a record $206.7M.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-44.63M

Investing Cash Flow (TTM)

8.90M

Financing Cash Flow (TTM)

79.46M

Free Cash Flow (TTM)

-73.80M

Capital Expenditure (TTM)

-29.17M

Net Change in Cash (TTM)

43.74M

Analyst Trends and Forecast

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$862.87M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.82

PB Ratio (TTM)

0.49

Earnings Yield % (TTM)

-222.68%

Earnings Yield % (FWD)

-2.67%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$13.36

Company Debt

Total Debt

$249.54M

LT Debt

$223.25M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$13.80M

Total Cash

$204.62M

Debt to Equity

0.20

Issuance of Debt (TTM)

-$13.80M

Repayment of Debt (TTM)

-$6.51M

Key Statistics

Open

$6.48

Volume / Avg.

1.68M / 3.38M

Day Range

$6.36 - $6.75

52 Wk Range

3.51 - 23.20

Market Cap

$748.49M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

12.36%

Days to Cover

5.95

About

Sector

Health Care

Industry

Pharmaceuticals

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tilray Brands (TLRY) stock?

You can purchase shares of Tilray Brands (NASDAQ:TLRY) through any online brokerage.

View our list of the best stock brokerages

Who are Tilray Brands (TLRY) competitors?

Other companies in Tilray Brands’s space includes: Zevra Therapeutics Inc (NASDAQ:ZVRA), Theravance Biopharma Inc (NASDAQ:TBPH), GH Research PLC (NASDAQ:GHRS), Bioage Labs Inc (NASDAQ:BIOA) and Xeris Biopharma Holdings Inc (NASDAQ:XERS).

What is the forecast, or price target, for Tilray Brands (TLRY) stock?

Tilray Brands has a consensus price target of $3.96.

What is the current price for Tilray Brands (TLRY)?

The stock price for Tilray Brands (NASDAQ: TLRY) is $6.44 last updated April 13, 2026 at 9:30 AM EDT.

Does Tilray Brands (TLRY) pay a dividend?

There are no upcoming dividends for Tilray Brands.

When is Tilray Brands (NASDAQ:TLRY) reporting earnings?

Tilray Brands does not have any upcoming earnings scheduled.

Is Tilray Brands (TLRY) going to split?

There is no upcoming split for Tilray Brands.

What sector and industry does Tilray Brands (TLRY) operate in?

Tilray Brands is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Zevra Therapeutics Inc

NASDAQ:ZVRA

$9.58

1.16%

Theravance Biopharma Inc

Xeris Biopharma Holdings Inc

NASDAQ:XERS

$5.95

1.62%

Phathom Pharmaceuticals Inc

NASDAQ:PHAT

$12.59

0.79%

Aquestive Therapeutics Inc

NASDAQ:AQST

$4.17

2.08%

Esperion Therapeutics Inc

NASDAQ:ESPR

$2.18

0.46%

Key Statistics

Open

$6.48

Volume / Avg.

1.68M / 3.38M

Day Range

$6.36 - $6.75

52 Wk Range

3.51 - 23.20

Market Cap

$748.49M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

12.36%

Days to Cover

5.95

Recent Tilray Brands Inc News

What's Going On With Tilray Brands Stock On Wednesday?

Tilray shares gained after launching a high-potency cannabis brand, with innovation and strong momentum outweighing mixed technical signals.

Nabaparna Bhattacharya

Tilray Stock Continues To Climb After Earnings Beat, Record Revenue

Tilray Brands shares are trading higher Thursday afternoon after the company's fiscal Q3 results topped Wall Street expectations.

Henry Khederian

Tilray Brands Reaffirms Outlook After Record Quarter

Tilray (TLRY) shares jump in premarket after record Q3 results. Adjusted EPS of $0.02 beats estimates as revenue hits a record $206.7M.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-44.63M

Investing Cash Flow (TTM)

8.90M

Financing Cash Flow (TTM)

79.46M

Free Cash Flow (TTM)

-73.80M

Capital Expenditure (TTM)

-29.17M

Net Change in Cash (TTM)

43.74M

Analyst Trends and Forecast

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$862.87M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.82

PB Ratio (TTM)

0.49

Earnings Yield % (TTM)

-222.68%

Earnings Yield % (FWD)

-2.67%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$13.36

Company Debt

Total Debt

$249.54M

LT Debt

$223.25M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$13.80M

Total Cash

$204.62M

Debt to Equity

0.20

Issuance of Debt (TTM)

-$13.80M

Repayment of Debt (TTM)

-$6.51M

Key Statistics

Open

$6.48

Volume / Avg.

1.68M / 3.38M

Day Range

$6.36 - $6.75

52 Wk Range

3.51 - 23.20

Market Cap

$748.49M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

12.36%

Days to Cover

5.95

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry